HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Other Non-Current Assets (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Other Non-Current Assets came in at $34.2 million in Q2 2026, down 15.83% year-over-year from $40.6 million in Q2 2025, and down 12.08% quarter-over-quarter from $38.9 million in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Other Non-Current Assets (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Other Non-Current Assets for 12 consecutive years, with $34.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets fell 15.83% year-over-year to $34.2 million in Q2 2026; TTM through Jun 2026 was $34.2 million, a 15.83% decrease from a year earlier, with the FY2025 full-year figure at $38.9 million, up 212.51% from the prior year.
  • Other Non-Current Assets was $34.2 million for Q2 2026 at HUTCHMED (China), down from $38.9 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $45.0 million in Q2 2022 and troughed at $12.4 million in Q4 2024.
  • A 5-year average of $36.0 million and a median of $39.2 million in 2023 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets jumped 212.51% in 2025 and declined 15.83% in 2026, its largest moves.
  • Over 5 years, Other Non-Current Assets stood at $39.8 million in 2022, then decreased by 0.72% to $39.5 million in 2023, then slumped by 68.54% to $12.4 million in 2024, then jumped by 212.51% to $38.9 million in 2025, then dropped by 12.08% to $34.2 million in 2026.
  • The last three Other Non-Current Assets figures came in at $34.2 million (Q2 2026), $38.9 million (Q4 2025), and $40.6 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn 29.59 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - 34.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.19 Mn
Dec 31, 2025 38.89 Mn
Jun 30, 2025 40.62 Mn
Dec 31, 2024 12.44 Mn
Jun 30, 2024 37.27 Mn
Jun 30, 2023 39.55 Mn
Dec 31, 2022 39.83 Mn
Jun 30, 2022 45.04 Mn
Dec 31, 2021 21.55 Mn
Jun 30, 2021 24.71 Mn
Mar 31, 2021 26.97 Mn
Dec 31, 2020 20.17 Mn
Jun 30, 2020 6.64 Mn
Dec 31, 2019 5.78 Mn
Sep 30, 2019 6.58 Mn
Jun 30, 2019 6.77 Mn
Mar 31, 2019 6.77 Mn
Dec 31, 2018 292,000.00
Jun 30, 2018 6.58 Mn
Dec 31, 2017 123,000.00